• Loading stock data...
Est. 2004

LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

Saturday 10/20/2018
SMALL CAP MARKET NEWS

We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.


LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

GBLX

  • 6:15 PM

    Las Vegas, June 27, 2018 (GLOBE NEWSWIRE) — GB Sciences, Inc. (OTCQB: GBLX) has filed a new provisional patent application on the use of cannabis-based therapies for the manipulation of cannabis-sensitive ion channels in sensory neurons that contribute to chronic inflammatory pain conditions, peripheral neuropathy, urinary cystitis, asthma, and specific types of hearing loss. The GB Sciences drug development team believes that these new cannabis-based treatments could well herald the dawning of ‘individualized medicines’ from the cannabis plant by re-establishing

    Read more
  • 11:07 AM

    LAS VEGAS, March 28, 2018 The deal positions GB Sciences as a truly vertically integrated company in the Las Vegas, Nevada, cannabis market: – Cultivation license increases growing capacity – Production license expands proprietary product line to edibles, oils and vapes – Dispensary license creates higher profit margins allowing the company to sell finished products directly to the retail consumer LAS VEGAS, March 28, 2018 /PRNewswire/ — GB Sciences, Inc. (OTCQB: GBLX) is extremely pleased to announce it has signed a letter of intent to purchase 100%

    Read more
  • 2:30 PM

    LAS VEGAS, Oct. 23, 2017 /PRNewswire/GBLX, — GB Sciences, Inc. (OTCQB: GBLX) projects sales of $500,000 in October and continued sales of at least $500,000 per month over the next three months. GB Sciences recorded unaudited sales of approximately $320,000 in the three months ended 9/30/17. The company is operating at 200 grow lights, which is only 30% of its expected final capacity after build out is completed. After the final build out, cultivation revenues will continue to increase with a target flower capacity of $18Million annually. The company is expected

    Read more
  • 1:25 PM

    LAS VEGAS, Sept. 18, 2017 /PRNewswire/ — GB Sciences, Inc. (OTCQB: GBLX) announces that Louisiana State University (LSU) AgCenter has posted comments on the recently finalized agreement between GB Sciences Louisiana LLC, a subsidiary of GB Sciences, and the LSUag Center.   http://www.lsuagcenter.com/profiles/tblanchard/articles/page1505685314158 About GB Sciences, Inc. GB Sciences, Inc. (GBLX) is a diverse cannabis company, focused on standardized cultivation and production methods; as well as biopharmaceutical research and development. The Company’s goal is creating safe, standardized, pharmaceutical-grade, cannabinoid therapies that target a variety of

    Read more
  • 1:32 PM

    The first cannabis crop harvest yielded 133 pounds of product from 45 lights. 63 pounds were sold as premium flower, with 66.5 pounds held back for conversion to medical grade cannabis oil. PR Newswire LAS VEGAS, July 5, 2017 LAS VEGAS, July 5, 2017, GBLX, /PRNewswire/ — GB Sciences, Inc. (OTCQB: GBLX) has harvested its first crop and sold 63 pounds of premium flower while holding back 66.5 pounds for conversion to medical grade oil. Based on conservative estimates and production volumes,

    Read more
  • 10:42 AM

    The LSU Agricultural Center has one of the only two licenses granted by the State of Louisiana to cultivate, distribute and sell medical cannabis. In addition, GB Sciences will have first rights to commercialize any inventions or discoveries of the research center. PR Newswire LAS VEGAS, June 26, 2017, GBLX, LAS VEGAS, June 26, 2017 /PRNewswire/ — GB Sciences, Inc. (OTCQB: GBLX) secures bid to Louisiana State University (LSU) and receives authorization from the LSU Board of Supervisors to proceed with

    Read more
Public Wire Banner